Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Surgeons complete world’s first robotic eye operation
Surgeon using the robot
The robot operates through a single hole in the eye that is less than 1mm in diameter.

Procedure may be used to develop novel treatments for blindness

The world's first eye operation using a robot has been successfully completed at Oxford's John Radcliffe Hospital.

Surgeons remotely controlled the robot to lift a membrane 100th of a millimetre thick from the retina at the back of an eye.

Patient Dr William Bever is the first person to ever undergo the experimental procedure and said that his sight "is coming back".

Surgeons hope the procedure will eventually be used to develop novel treatments for blindness that are not possible with the human hand.

"There is no doubt in my mind that we have just witnessed a vision of eye surgery in the future," said Professor Robert MacLaren, who led the surgery.

The robot operates through a single hole in the eye that is less than 1mm in diameter. It is designed to eliminate unwanted tremors in the surgeon's hand - such as through their pulse - so tiny manipulations can be carried out safely.

Surgeons control the robot with a joystick and touchscreen outside the eye. This gives them a notable advantage as significant movements of the joystick result in tiny movements of the robot.

While robots have been developed for the large-scale surgery, this is the first time a device has been available that achieves the three dimensional precision required to operate inside the human eye.

"Current technology with laser scanners and microscopes allows us to monitor retinal diseases at the microscopic level, but the things we see are beyond the physiological limit of what the human hand can operate on," explains Professor MacLaren.

"With a robotic system, we open up a whole new chapter of eye operations that currently cannot be performed."

Speaking at his follow up visit at the Oxford Eye Hospital, Dr Beaver said: "My sight is coming back. I am delighted that my surgery went so well and I feel honoured to be part of this pioneering research project."

Professor MacLaren added: "This will help to develop novel surgical treatments for blindness, such as gene therapy and stem cells, which need to be inserted under the retina with a high degree of precision."

Image (C) Oxford University Hospitals

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.